Post-immunobiotics increase resistance to primary respiratory syncytial virus infection and secondary pneumococcal pneumonia
äºBeneficial MicrobesSearch for other papers by F. Raya Tonetti in
Current site
Google Scholar
Livestock Immunology Unit, International Education and Research Center for Food Agricultural Immunology (CFAI), Graduate School of Agricultural Science, Tohoku University, 468-1 Aramaki Aza Aoba, Aobaku, 980-8572 Sendai, Japan.
Search for other papers by M. Tomokiyo in
Current site
Google Scholar
Livestock Immunology Unit, International Education and Research Center for Food Agricultural Immunology (CFAI), Graduate School of Agricultural Science, Tohoku University, 468-1 Aramaki Aza Aoba, Aobaku, 980-8572 Sendai, Japan.
Search for other papers by K. Fukuyama in
Current site
Google Scholar
Search for other papers by M. Elean in
Current site
Google Scholar
Search for other papers by R. Ortiz Moyano in
Current site
Google Scholar
Livestock Immunology Unit, International Education and Research Center for Food Agricultural Immunology (CFAI), Graduate School of Agricultural Science, Tohoku University, 468-1 Aramaki Aza Aoba, Aobaku, 980-8572 Sendai, Japan.
Search for other papers by H. Yamamuro in
Current site
Google Scholar
Livestock Immunology Unit, International Education and Research Center for Food Agricultural Immunology (CFAI), Graduate School of Agricultural Science, Tohoku University, 468-1 Aramaki Aza Aoba, Aobaku, 980-8572 Sendai, Japan.
Search for other papers by R. Shibata in
Current site
Google Scholar
Search for other papers by S. Quilodran-Vega in
Current site
Google Scholar
Search for other papers by S. Kurata in
Current site
Google Scholar
Livestock Immunology Unit, International Education and Research Center for Food Agricultural Immunology (CFAI), Graduate School of Agricultural Science, Tohoku University, 468-1 Aramaki Aza Aoba, Aobaku, 980-8572 Sendai, Japan.
Search for other papers by J. Villena in
Current site
Google Scholar
Livestock Immunology Unit, International Education and Research Center for Food Agricultural Immunology (CFAI), Graduate School of Agricultural Science, Tohoku University, 468-1 Aramaki Aza Aoba, Aobaku, 980-8572 Sendai, Japan.
Search for other papers by H. Kitazawa in
Current site
Google Scholar
Previously, we demonstrated that post-immunobiotics derived from Lactobacillus gasseri TMT36, TMT39, and TMT40 strains (HK36, HK39 and HK40, respectively) differentially regulated Toll-like receptor 3 (TLR3)-mediated antiviral respiratory immunity in infant mice. In this work, we investigated whether the HK36, HK39 and HK40 nasal treatments were able to improve the resistance against primary respiratory syncytial virus (RSV) infection and secondary pneumococcal pneumonia. Our results demonstrated that the three treatments increased the resistance to primary viral infection by reducing variations in body weight, RSV titers and lung damage of infected infant mice. Post-immunobiotics significantly enhanced the expressions of interferon (IFN)-λ, IFN-β, IFN-γ, interleukin(IL) - 1β, IL-6, IL-27, Mx1, RNAseL and 2â-5â-oligoadenylate synthetase 1 (OAS1) genes and decreased tumour necrosis factor (TNF)-α in alveolar macrophages of RSV-challenged mice. In addition, the studies in the model of RSV-Streptococcus pneumoniae superinfection showed that the HK39 and HK40 treatments were capable of reducing lung damage, lung bacterial cell counts, and the dissemination of S. pneumoniae into the blood of infant mice. The protective effect was associated with increases in IFN-β, IFN-γ, IL-10, and IL-27 in the respiratory tract. This study demonstrates that the nasal application of the post-immunobiotics HK39 and HK40 stimulates innate respiratory immunity and enhances the defences against primary RSV infection and secondary pneumococcal pneumonia offering an alternative to combat respiratory superinfections in children, which can be fatal.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
-
Abt, M.C., Osborne, L.C., Monticelli, L.A., Doering, T.A., Alenghat, T., Sonnenberg, G.F., Paley, M.A., Antenus, M., Williams, K.L., Erikson, J., Wherry, E.J. and Artis, D., 2012. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 37: 158-170. https://doi.org/10.1016/j.immuni.2012.04.011
-
Andrade, B.G.N., Cuadrat, R.R.C., Tonetti, F.R., Kitazawa, H. and Villena, J., 2022. The role of respiratory microbiota in the protection against viral diseases: respiratory commensal bacteria as next-generation probiotics for COVID-19. Bioscience of Microbiota, Food and Health 41: 94-102. https://doi.org/10.12938/bmfh.2022-009
-
Avadhanula, V., Rodriguez, C.A., Devincenzo, J.P., Wang, Y., Webby, R.J., Ulett, G.C. and Adderson, E.E., 2006. Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner. Journal of Virology 80: 1629-1636. https://doi.org/10.1128/JVI.80.4.1629-1636.2006
-
Battles, M.B. and McLellan, J.S., 2019. Respiratory syncytial virus entry and how to block it. Nature Reviews: Microbiology 17: 233-245. https://doi.org/10.1038/s41579-019-0149-x
-
Bohmwald, K., Espinoza, J.A., Pulgar, R.A., Jara, E.L. and Kalergis, A.M., 2017. Functional impairment of mononuclear phagocyte system by the human respiratory syncytial virus. Frontiers in Immunology 8: 1643. https://doi.org/10.3389/fimmu.2017.01643
-
Bosch, A.A., Biesbroek, G., Trzcinski, K., Sanders, E.A. and Bogaert, D., 2013. Viral and bacterial interactions in the upper respiratory tract. PLoS Pathogens 9: e1003057. https://doi.org/10.1371/journal.ppat.1003057
-
Cebey-Lopez, M., Pardo-Seco, J., Gomez-Carballa, A., Martinon-Torres, N., Martinon-Sanchez, J.M., Justicia-Grande, A., Rivero-Calle, I., Pinnock, E., Salas, A., Fink, C., Martinon-Torres, F. and the GENDRES network, 2016. Bacteremia in children hospitalized with respiratory syncytial virus infection. PLoS One 11: e0146599. https://doi.org/10.1371/journal.pone.0146599
-
Clua, P., Kanmani, P., Zelaya, H., Tada, A., Kober, A., Salva, S., Alvarez, S., Kitazawa, H. and Villena, J., 2017. Peptidoglycan from immunobiotic Lactobacillus rhamnosus improves resistance of infant mice to respiratory syncytial viral infection and secondary pneumococcal pneumonia. Frontiers in Immunology 8: 948. https://doi.org/10.3389/fimmu.2017.00948
-
Clua, P., Tomokiyo, M., Raya Tonetti, F., Islam, M., GarcÃa Castillo, V., Marcial, G., Salva, S., Alvarez, S., Takahashi, H. and Kurata, S.J.C., 2020. The role of alveolar macrophages in the improved protection against respiratory syncytial virus and pneumococcal superinfection induced by the peptidoglycan of Lactobacillus rhamnosus CRL1505. Cells 9: 1653.
'The role of alveolar macrophages in the improved protection against respiratory syncytial virus and pneumococcal superinfection induced by the peptidoglycan of Lactobacillus rhamnosus CRL1505 ' () 9 Cells : 1653.
-
De Almeida Nagata, D.E., Demoor, T., Ptaschinski, C., Ting, H.A., Jang, S., Reed, M., Mukherjee, S. and Lukacs, N.W., 2014. IL-27R-mediated regulation of IL-17 controls the development of respiratory syncytial virus-associated pathogenesis. American Journal of Pathology 184: 1807-1818. https://doi.org/10.1016/j.ajpath.2014.02.004
-
Eguchi, K., Fujitani, N., Nakagawa, H. and Miyazaki, T., 2019. Prevention of respiratory syncytial virus infection with probiotic lactic acid bacterium Lactobacillus gasseri SBT2055. Scientific Reports 9: 4812. https://doi.org/10.1038/s41598-019-39602-7
-
Eichinger, K.M., Egana, L., Orend, J.G., Resetar, E., Anderson, K.B., Patel, R. and Empey, K.M., 2015. Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal mice. Respiratory Research 16: 122. https://doi.org/10.1186/s12931-015-0282-7
-
Fang, R., Hara, H., Sakai, S., Hernandez-Cuellar, E., Mitsuyama, M., Kawamura, I. and Tsuchiya, K., 2014. Type I interferon signaling regulates activation of the absent in melanoma 2 inflammasome during Streptococcus pneumoniae infection. Infection and Immunity 82: 2310-2317. https://doi.org/10.1128/IAI.01572-14
-
Fiore, W., Arioli, S. and Guglielmetti, S., 2020. The neglected microbial components of commercial probiotic formulations. Microorganisms 8: 1177. https://doi.org/10.3390/microorganisms8081177
-
Gomez, J.C., Yamada, M., Martin, J.R., Dang, H., Brickey, W.J., Bergmeier, W., Dinauer, M.C. and Doerschuk, C.M., 2015. Mechanisms of interferon-gamma production by neutrophils and its function during Streptococcus pneumoniae pneumonia. American Journal of Respiratory Cell and Molecular Biology 52: 349-364. https://doi.org/10.1165/rcmb.2013-0316OC
-
Goritzka, M., Makris, S., Kausar, F., Durant, L.R., Pereira, C., Kumagai, Y., Culley, F.J., Mack, M., Akira, S. and Johansson, C., 2015. Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes. Journal of Experimental Medicine 212: 699-714. https://doi.org/10.1084/jem.20140825
-
Griffiths, C., Drews, S.J. and Marchant, D.J., 2017. Respiratory syncytial virus: infection, detection, and new options for prevention and treatment. Clinical Microbiology Reviews 30: 277-319. https://doi.org/10.1128/CMR.00010-16
-
Hament, J.M., Aerts, P.C., Fleer, A., van Dijk, H., Harmsen, T., Kimpen, J.L. and Wolfs, T.F., 2005. Direct binding of respiratory syncytial virus to pneumococci: a phenomenon that enhances both pneumococcal adherence to human epithelial cells and pneumococcal invasiveness in a murine model. Pediatric Research 58: 1198-1203. https://doi.org/10.1203/01.pdr.0000188699.55279.1b
-
Harata, G., He, F., Hiruta, N., Kawase, M., Kubota, A., Hiramatsu, M. and Yausi, H., 2010. Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responses. Letters in Applied Microbiology 50: 597-602. https://doi.org/10.1111/j.1472-765X.2010.02844.x
-
Harker, J.A., Yamaguchi, Y., Culley, F.J., Tregoning, J.S. and Openshaw, P.J., 2014. Delayed sequelae of neonatal respiratory syncytial virus infection are dependent on cells of the innate immune system. Journal of Virology 88: 604-611. https://doi.org/10.1128/JVI.02620-13
-
Hori, T., Kiyoshima, J., Shida, K. and Yasui, H., 2001. Effect of intranasal administration of Lactobacillus casei Shirota on influenza virus infection of upper respiratory tract in mice. Clinical and Diagnostic Laboratory Immunology 8: 593-597. https://doi.org/10.1128/CDLI.8.3.593-597.2001
-
Hunter, C.A., 2005. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nature Reviews: Immunology 5: 521-531. https://doi.org/10.1038/nri1648
-
Izumo, T., Maekawa, T., Ida, M., Noguchi, A., Kitagawa, Y., Shibata, H., Yasui, H. and Kiso, Y., 2010. Effect of intranasal administration of Lactobacillus pentosus S-PT84 on influenza virus infection in mice. International Immunopharmacology 10: 1101-1106. https://doi.org/10.1016/j.intimp.2010.06.012
-
Kadooka, Y., Tominari, K., Sakai, F. and Yasui, H., 2012. Prevention of rotavirus-induced diarrhea by preferential secretion of IgA in breast milk via maternal administration of Lactobacillus gasseri SBT2055. Journal of Pediatric Gastroenterology and Nutrition 55: 66-71. https://doi.org/10.1097/MPG.0b013e3182533a2b
-
Kanmani, P., Albarracin, L., Kobayashi, H., Hebert, E.M., Saavedra, L., Komatsu, R., Gatica, B., Miyazaki, A., Ikeda-Ohtsubo, W., Suda, Y., Aso, H., Egusa, S., Mishima, T., Salas-Burgos, A., Takahashi, H., Villena, J. and Kitazawa, H., 2018. Genomic characterization of Lactobacillus delbrueckii TUA4408L and evaluation of the antiviral activities of its extracellular polysaccharides in porcine intestinal epithelial cells. Frontiers in Immunology 9: 2178. https://doi.org/10.3389/fimmu.2018.02178
-
Kanmani, P., Clua, P., Vizoso-Pinto, M.G., Rodriguez, C., Alvarez, S., Melnikov, V., Takahashi, H., Kitazawa, H. and Villena, J., 2017. Respiratory commensal bacteria Corynebacterium pseudodiphtheriticum improves resistance of infant mice to respiratory syncytial virus and Streptococcus pneumoniae superinfection. Frontiers in Microbiology 8: 1613. https://doi.org/10.3389/fmicb.2017.01613
-
Kawase, M., He, F., Kubota, A., Yoda, K., Miyazawa, K. and Hiramatsu, M., 2012. Heat-killed Lactobacillus gasseri TMC0356 protects mice against influenza virus infection by stimulating gut and respiratory immune responses. FEMS Immunology and Medical Microbiology 64: 280-288. https://doi.org/10.1111/j.1574-695X.2011.00903.x
-
Kolli, D., Gupta, M.R., Sbrana, E., Velayutham, T.S., Chao, H., Casola, A. and Garofalo, R.P., 2014. Alveolar macrophages contribute to the pathogenesis of human metapneumovirus infection while protecting against respiratory syncytial virus infection. American Journal of Respiratory Cell and Molecular Biology 51: 502-515. https://doi.org/10.1165/rcmb.2013-0414OC
-
Koppe, U., Hogner, K., Doehn, J.M., Muller, H.C., Witzenrath, M., Gutbier, B., Bauer, S., Pribyl, T., Hammerschmidt, S., Lohmeyer, J., Suttorp, N., Herold, S. and Opitz, B., 2012. Streptococcus pneumoniae stimulates a STING- and IFN regulatory factor 3-dependent type I IFN production in macrophages, which regulates RANTES production in macrophages, cocultured alveolar epithelial cells, and mouse lungs. Journal of Immunology 188: 811-817. https://doi.org/10.4049/jimmunol.1004143
-
LeMessurier, K.S., Hacker, H., Chi, L., Tuomanen, E. and Redecke, V., 2013. Type I interferon protects against pneumococcal invasive disease by inhibiting bacterial transmigration across the lung. PLoS Pathogens 9: e1003727. https://doi.org/10.1371/journal.ppat.1003727
-
Liu, L., Johnson, H.L., Cousens, S., Perin, J., Scott, S., Lawn, J.E., Rudan, I., Campbell, H., Cibulskis, R., Li, M., Mathers, C. and Black, R.E., for the Child Health Epidemiology Reference Group of WHO and UNICEF, 2012. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. The Lancet 379: 2151-2161. https://doi.org/10.1016/S0140-6736(12)60560-1
-
Maier, B.B., Hladik, A., Lakovits, K., Korosec, A., Martins, R., Kral, J.B., Mesteri, I., Strobl, B., Muller, M., Kalinke, U., Merad, M. and Knapp, S., 2016. Type I interferon promotes alveolar epithelial type II cell survival during pulmonary Streptococcus pneumoniae infection and sterile lung injury in mice. European Journal of Immunology 46: 2175-2186. https://doi.org/10.1002/eji.201546201
-
Mejias, A., RodrÃguez-Fernández, R., Oliva, S., Peeples, M.E. and Ramilo, O., 2020. The journey to a respiratory syncytial virus vaccine. Annals of Allergy, Asthma & Immunology 125: 36-46. https://doi.org/https://doi.org/10.1016/j.anai.2020.03.017
-
Mezei, A., Cohen, J., Renwick, M.J., Atwell, J. and Portnoy, A., 2021. Mathematical modelling of respiratory syncytial virus (RSV) in low- and middle-income countries: A systematic review. Epidemics 35: 100444. https://doi.org/https://doi.org/10.1016/j.epidem.2021.100444
-
Muscedere, J., Ofner, M., Kumar, A., Long, J., Lamontagne, F., Cook, D., McGeer, A., Chant, C., Marshall, J., Jouvet, P. and Fowler, R. for the ICU-FLU Group and the Canadian Critical Care Trials Group, 2013. The occurrence and impact of bacterial organisms complicating critical care illness associated with 2009 influenza A(H1N1) infection. Chest 144: 39-47. https://doi.org/10.1378/chest.12-1861
-
Nakayama, Y., Moriya, T., Sakai, F., Ikeda, N., Shiozaki, T., Hosoya, T., Nakagawa, H. and Miyazaki, T., 2014. Oral administration of Lactobacillus gasseri SBT2055 is effective for preventing influenza in mice. Scientific Reports 4: 4638. https://doi.org/10.1038/srep04638
-
Nataraj, B.H., Ali, S.A., Behare, P.V. and Yadav, H., 2020. Postbioticsparabiotics: the new horizons in microbial biotherapy and functional foods. Microbial Cell Factories 19: 168. https://doi.org/10.1186/s12934-020-01426-w
-
Pacheco, G.A., Galvez, N.M.S., Soto, J.A., Andrade, C.A. and Kalergis, A.M., 2021. Bacterial and viral coinfections with the human respiratory syncytial virus. Microorganisms 9: 1293. https://doi.org/10.3390/microorganisms9061293
-
Pot, C., Apetoh, L., Awasthi, A. and Kuchroo, V.K., 2011. Induction of regulatory Tr1 cells and inhibition of T(H)17 cells by IL-27. Seminars in Immunology 23: 438-445. https://doi.org/10.1016/j.smim.2011.08.003
-
Pyle, C.J., Uwadiae, F.I., Swieboda, D.P. and Harker, J.A., 2017. Early IL-6 signalling promotes IL-27 dependent maturation of regulatory T cells in the lungs and resolution of viral immunopathology. PLoS Pathogens 13: e1006640. https://doi.org/10.1371/journal.ppat.1006640
-
Salminen, S., Collado, M.C., Endo, A., Hill, C., Lebeer, S., Quigley, E.M.M., Sanders, M.E., Shamir, R., Swann, J.R., Szajewska, H. and Vinderola, G., 2021. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nature Reviews Gastroenterology and Hepatology 18: 649-667. https://doi.org/10.1038/s41575-021-00440-6
-
Schultz, C., Richter, N., Moller, J.C. and Bucsky, P., 2001. IFN-gamma response and IL-8 plasma levels in neonates with respiratory syncytial virus bronchiolitis. European Respiratory Journal 17: 321-324. https://doi.org/10.1183/09031936.01.17203210
-
Smith, C.M., Sandrini, S., Datta, S., Freestone, P., Shafeeq, S., Radhakrishnan, P., Williams, G., Glenn, S.M., Kuipers, O.P., Hirst, R.A., Easton, A.J., Andrew, P.W. and OâCallaghan, C., 2014. Respiratory syncytial virus increases the virulence of Streptococcus pneumoniae by binding to penicillin binding protein 1a. A new paradigm in respiratory infection. American Journal of Respiratory and Critical Care Medicine 190: 196-207. https://doi.org/10.1164/rccm.201311-2110OC
-
Stumhofer, J.S. and Hunter, C.A., 2008. Advances in understanding the anti-inflammatory properties of IL-27. Immunology Letters 117: 123-130. https://doi.org/10.1016/j.imlet.2008.01.011
-
Tomokiyo, M., Tonetti, F.R., Yamamuro, H., Shibata, R., Fukuyama, K., Gobbato, N., Albarracin, L., Rajoka, M.S.R., Kober, A., Ikeda-Ohtsubo, W., Villena, J. and Kitazawa, H., 2022. Modulation of alveolar macrophages by postimmunobiotics: impact on TLR3-mediated antiviral respiratory immunity. Cells 11: 2986. https://doi.org/10.3390/cells11192986
-
Tomosada, Y., Chiba, E., Zelaya, H., Takahashi, T., Tsukida, K., Kitazawa, H., Alvarez, S. and Villena, J., 2013. Nasally administered Lactobacillus rhamnosus strains differentially modulate respiratory antiviral immune responses and induce protection against respiratory syncytial virus infection. BMC Immunology 14: 40. https://doi.org/10.1186/1471-2172-14-40
-
Tonetti, F.R., Islam, M.A., Vizoso-Pinto, M.G., Takahashi, H., Kitazawa, H. and Villena, J., 2020. Nasal priming with immunobiotic lactobacilli improves the adaptive immune response against influenza virus. International Immunopharmacology 78: 106115. https://doi.org/10.1016/j.intimp.2019.106115
-
Villena, J. and Kitazawa, H., 2020. The modulation of mucosal antiviral immunity by immunobiotics: could they offer any benefit in the SARS-CoV-2 pandemic? Frontiers in Physiology 11: 699. https://doi.org/10.3389/fphys.2020.00699
-
Villena, J., Li, C., Vizoso-Pinto, M.G., Sacur, J., Ren, L. and Kitazawa, H., 2021. Lactiplantibacillus plantarum as a potential adjuvant and delivery system for the development of SARS-CoV-2 oral vaccines. Microorganisms 9: 683. https://doi.org/10.3390/microorganisms9040683
-
Villena, J., Oliveira, M.L., Ferreira, P.C., Salva, S. and Alvarez, S., 2011. Lactic acid bacteria in the prevention of pneumococcal respiratory infection: future opportunities and challenges. International Immunopharmacology 11: 1633-1645. https://doi.org/10.1016/j.intimp.2011.06.004
-
Weinberger, D.M., Givon-Lavi, N., Shemer-Avni, Y., Bar-Ziv, J., Alonso, W.J., Greenberg, D. and Dagan, R., 2013. Influence of pneumococcal vaccines and respiratory syncytial virus on alveolar pneumonia, Israel. Emerging Infectious Diseases 19: 1084-1091. https://doi.org/10.3201/eid1907.121625
-
Yao, Y., Jeyanathan, M., Haddadi, S., Barra, N.G., Vaseghi-Shanjani, M., Damjanovic, D., Lai, R., Afkhami, S., Chen, Y., Dvorkin-Gheva, A., Robbins, C.S., Schertzer, J.D. and Xing, Z., 2018. Induction of autonomous memory alveolar macrophages requires T cell help and is critical to trained immunity. Cell 175: 1634-1650. https://doi.org/10.1016/j.cell.2018.09.042
-
Yoda, K., He, F., Miyazawa, K., Kawase, M., Kubota, A. and Hiramatsu, M., 2012. Orally administered heat-killed Lactobacillus gasseri TMC0356 alters respiratory immune responses and intestinal microbiota of diet-induced obese mice. Journal of Applied Microbiology 113: 155-162. https://doi.org/10.1111/j.1365-2672.2012.05316.x
-
Zelaya, H., Alvarez, S., Kitazawa, H. and Villena, J., 2016. Respiratory antiviral immunity and immunobiotics: beneficial effects on inflammation-coagulation interaction during influenza virus infection. Frontiers in Immunology 7: 633. https://doi.org/10.3389/fimmu.2016.00633
-
Zelaya, H., Tada, A., Vizoso-Pinto, M.G., Salva, S., Kanmani, P., Aguero, G., Alvarez, S., Kitazawa, H. and Villena, J., 2015. Nasal priming with immunobiotic Lactobacillus rhamnosus modulates inflammation-coagulation interactions and reduces influenza virus-associated pulmonary damage. Inflammation Research 64: 589-602. https://doi.org/10.1007/s00011-015-0837-6
Supplementary Materials
| å ¨é¨æé´ | è¿å»ä¸å¹´ | è¿å»30天 | |
|---|---|---|---|
| æè¦æµè§æ¬¡æ° | 1195 | 257 | 12 |
| å ¨ææµè§æ¬¡æ° | 38 | 8 | 1 |
| PDFä¸è½½æ¬¡æ° | 37 | 14 | 0 |
Post-immunobiotics increase resistance to primary respiratory syncytial virus infection and secondary pneumococcal pneumonia
äºBeneficial MicrobesSearch for other papers by F. Raya Tonetti in
Current site
Google Scholar
PubMed
Livestock Immunology Unit, International Education and Research Center for Food Agricultural Immunology (CFAI), Graduate School of Agricultural Science, Tohoku University, 468-1 Aramaki Aza Aoba, Aobaku, 980-8572 Sendai, Japan.
Search for other papers by M. Tomokiyo in
Current site
Google Scholar
PubMed
Livestock Immunology Unit, International Education and Research Center for Food Agricultural Immunology (CFAI), Graduate School of Agricultural Science, Tohoku University, 468-1 Aramaki Aza Aoba, Aobaku, 980-8572 Sendai, Japan.
Search for other papers by K. Fukuyama in
Current site
Google Scholar
PubMed
Search for other papers by M. Elean in
Current site
Google Scholar
PubMed
Search for other papers by R. Ortiz Moyano in
Current site
Google Scholar
PubMed
Livestock Immunology Unit, International Education and Research Center for Food Agricultural Immunology (CFAI), Graduate School of Agricultural Science, Tohoku University, 468-1 Aramaki Aza Aoba, Aobaku, 980-8572 Sendai, Japan.
Search for other papers by H. Yamamuro in
Current site
Google Scholar
PubMed
Livestock Immunology Unit, International Education and Research Center for Food Agricultural Immunology (CFAI), Graduate School of Agricultural Science, Tohoku University, 468-1 Aramaki Aza Aoba, Aobaku, 980-8572 Sendai, Japan.
Search for other papers by R. Shibata in
Current site
Google Scholar
PubMed
Search for other papers by S. Quilodran-Vega in
Current site
Google Scholar
PubMed
Search for other papers by S. Kurata in
Current site
Google Scholar
PubMed
Livestock Immunology Unit, International Education and Research Center for Food Agricultural Immunology (CFAI), Graduate School of Agricultural Science, Tohoku University, 468-1 Aramaki Aza Aoba, Aobaku, 980-8572 Sendai, Japan.
Search for other papers by J. Villena in
Current site
Google Scholar
PubMed
Livestock Immunology Unit, International Education and Research Center for Food Agricultural Immunology (CFAI), Graduate School of Agricultural Science, Tohoku University, 468-1 Aramaki Aza Aoba, Aobaku, 980-8572 Sendai, Japan.
Search for other papers by H. Kitazawa in
Current site
Google Scholar
PubMed
Previously, we demonstrated that post-immunobiotics derived from Lactobacillus gasseri TMT36, TMT39, and TMT40 strains (HK36, HK39 and HK40, respectively) differentially regulated Toll-like receptor 3 (TLR3)-mediated antiviral respiratory immunity in infant mice. In this work, we investigated whether the HK36, HK39 and HK40 nasal treatments were able to improve the resistance against primary respiratory syncytial virus (RSV) infection and secondary pneumococcal pneumonia. Our results demonstrated that the three treatments increased the resistance to primary viral infection by reducing variations in body weight, RSV titers and lung damage of infected infant mice. Post-immunobiotics significantly enhanced the expressions of interferon (IFN)-λ, IFN-β, IFN-γ, interleukin(IL) - 1β, IL-6, IL-27, Mx1, RNAseL and 2â-5â-oligoadenylate synthetase 1 (OAS1) genes and decreased tumour necrosis factor (TNF)-α in alveolar macrophages of RSV-challenged mice. In addition, the studies in the model of RSV-Streptococcus pneumoniae superinfection showed that the HK39 and HK40 treatments were capable of reducing lung damage, lung bacterial cell counts, and the dissemination of S. pneumoniae into the blood of infant mice. The protective effect was associated with increases in IFN-β, IFN-γ, IL-10, and IL-27 in the respiratory tract. This study demonstrates that the nasal application of the post-immunobiotics HK39 and HK40 stimulates innate respiratory immunity and enhances the defences against primary RSV infection and secondary pneumococcal pneumonia offering an alternative to combat respiratory superinfections in children, which can be fatal.
| å ¨é¨æé´ | è¿å»ä¸å¹´ | è¿å»30天 | |
|---|---|---|---|
| æè¦æµè§æ¬¡æ° | 1195 | 257 | 12 |
| å ¨ææµè§æ¬¡æ° | 38 | 8 | 1 |
| PDFä¸è½½æ¬¡æ° | 37 | 14 | 0 |
